Labs / CDMO: development & manufacturing
Aboleris Pharma
Gosselies, Belgium · aboleris-pharma.com
Aboleris Pharma is a clinical-stage biopharmaceutical company developing therapies to restore immune tolerance for autoimmune diseases and organ transplantation rejection. It is based in Gosselies, Belgium, and Nantes, France.
They take quote requests by email.
What they offer
Development of anti-CD45RC antibody therapies
Develops a novel class of antibodies targeting CD45RC to selectively deplete pathogenic Effector T and B cells while preserving Regulatory cells.
Immune tolerance therapeutics
Develops curative-intent therapies designed to reset the immune system and restore immune tolerance.
What they work on
- Modalities
- Small molecule, Antibody, Cell therapy
- Therapeutic areas
- autoimmune diseases, organ transplantation rejection, rheumatoid arthritis, inflammatory bowel disease, graft-versus-host disease, Sjögren's disease
- Sites
- Gosselies, Belgium · Nantes, France
- Founded
- 2015
Similar labs. CDI Labs, Esco Aster, Evotec, JPT Peptide Technologies
Found in a contract services directory. Listing built from aboleris-pharma.com. Work here? Claim this listing.